Redmile Group, LLC

Q3 2025 13F Holdings

  • Location
    san francisco, CA
  • Num holdings

    40

  • Value ($000)

    $1,027,816

  • Date Filed
    11/14/2025
  • Form type
    13F-HR
  • CIK
    0001425738
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
S
SRRK

SCHOLAR ROCK HLDG CORP

COM
80706P103
$145.40M
14 %

3,904,456

K
KRYS

KRYSTAL BIOTECH INC

COM
501147102
$116.75M
11 %

661,388

S
STOK

STOKE THERAPEUTICS INC

COM
86150R107
$98.13M
10 %

4,175,542

Z
ZYME

ZYMEWORKS INC

COM
98985Y108
$63.29M
6 %

3,705,750

---

ADC THERAPEUTICS SA

SHS
H0036K147
$62.67M
6 %

15,666,731

I
IMNM

IMMUNOME INC

COM
45257U108
$58.82M
6 %

5,023,385

---

LIVANOVA PLC

SHS
G5509L101
$48.55M
5 %

926,799

R
RGNX

REGENXBIO INC

COM
75901B107
$45.29M
4 %

4,693,389

A
AKRO

AKERO THERAPEUTICS INC

COM
00973Y108
$35.51M
4 %

747,818

N
NRIX

NURIX THERAPEUTICS INC

COM
67080M103
$33.99M
3 %

3,678,394

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 40